News brief.
A moratorium on new health plan mandates has passed North Carolina's House of Representatives by an overwhelming majority and appears to have little opposition in the Senate.
A similar bill died in Alabama last month, but only because "we pretty much ran out of time," explains the Senate majority leader there, Tom Butler, a Madison, Ala., pharmacist and primary backer of the bill. He says he introduced the bill at the behest of the local chapter of the National Federation of Independent Business.
Mandates have proliferated as organizations supporting patients with particular diseases have drafted legislation to make sure their preferred treatment is included in health care coverage and have paraded witnesses with dire stories of the consequences of care denied. "It becomes more of an emotional thing than about looking at what the long-term benefits are," explains Rep. E. David Redwine, a Shallotte, N.C. insurance broker and author of the North Carolina measure. The goal of the moratorium is to give lawmakers a chance to weigh the cost of a new demand against the amount of help it will provide. The North Carolina measure would expire Jan. 1, 2004, giving the state time to set up a procedure for conducting a cost-benefit analysis of any new suggested mandates.
The National Federation of Independent Business, which opposes all mandates that are spiking the cost of health insurance beyond the budgets of small employers, says that 15 states already have such procedures in place. Additional moratoriums are likely to be proposed in other states in the next year.
Of course, any moratorium passed by a legislative body can be overridden the next time a majority gets behind a new mandate. Redwine admits as much but counters that having the freeze on the books will give opponents of additional mandates a persuasive new tool, letting them say "let's give this time to work" before rushing into a new coverage demand.
Daniel Moskowitz. North Carolina halting health plan mandates. Business and Health 2001;6:17.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen